Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 16 Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, B-Cell 1

Interventions

Surveys and Questionnaires 13 Blood Specimen Collection 13 Specimen Handling 10 Magnetic Resonance Spectroscopy 5 Surgical Procedures, Operative 4 Radiotherapy 4 Observation 4 Data Collection 4 ribociclib 3 darolutamide 3 Watchful Waiting 3 Standard of Care 3 Patient Reported Outcome Measures 3 Mental Status and Dementia Tests 3 Interviews as Topic 3 Immune Checkpoint Inhibitors 3 Hepatectomy 3 Breath Tests 3 Biopsy 3 trastuzumab deruxtecan 2 palbociclib 2 atezolizumab 2 X-Rays 2 Ultrasonography 2 Tomography, X-Ray Computed 2 Sulfonylurea Compounds 2 Restraint, Physical 2 Neoadjuvant Therapy 2 Methods 2 Mass Screening 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × acalabrutinib × 30 days × Clear all

NCT05557695 2026-06-02

EPIC

AstraZeneca

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡